PET/MR of pediatric bone tumors: what the radiologist needs to know
- PMID: 35804163
- PMCID: PMC9826799
- DOI: 10.1007/s00256-022-04113-6
PET/MR of pediatric bone tumors: what the radiologist needs to know
Abstract
Integrated 2-deoxy-2-[fluorine-18]fluoro-D-glucose (18F-FDG) positron emission tomography (PET)/magnetic resonance (MR) imaging can provide "one stop" local tumor and whole-body staging in one session, thereby streamlining imaging evaluations and avoiding duplicate anesthesia in young children. 18F-FDG PET/MR scans have the benefit of lower radiation, superior soft tissue contrast, and increased patient convenience compared to 18F-FDG PET/computerized tomography scans. This article reviews the 18F-FDG PET/MR imaging technique, reporting requirements, and imaging characteristics of the most common pediatric bone tumors, including osteosarcoma, Ewing sarcoma, primary bone lymphoma, bone and bone marrow metastases, and Langerhans cell histiocytosis.
Keywords: Bone sarcoma; Magnetic resonance; PET/MR; Pediatric cancer; Positron emission tomography.
© 2022. The Author(s), under exclusive licence to International Skeletal Society (ISS).
Conflict of interest statement
Conflict of Interest Statement: The authors declare no potential conflicts of interest.
Figures
Similar articles
-
What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?Clin Orthop Relat Res. 2021 Aug 1;479(8):1768-1779. doi: 10.1097/CORR.0000000000001681. Clin Orthop Relat Res. 2021. PMID: 33635285 Free PMC article.
-
An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma.Pediatr Blood Cancer. 2013 Jul;60(7):1113-7. doi: 10.1002/pbc.24406. Epub 2012 Nov 28. Pediatr Blood Cancer. 2013. PMID: 23192939
-
Diagnostic Accuracy of 2-[18F]FDG-PET and whole-body DW-MRI for the detection of bone marrow metastases in children and young adults.Eur Radiol. 2022 Jul;32(7):4967-4979. doi: 10.1007/s00330-021-08529-x. Epub 2022 Jan 31. Eur Radiol. 2022. PMID: 35099603 Free PMC article.
-
Pediatric FDG PET/CT: Physiologic uptake, normal variants, and benign conditions [corrected].Radiographics. 2009 Sep-Oct;29(5):1487-500. doi: 10.1148/rg.295095024. Radiographics. 2009. PMID: 19755607 Review.
-
Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies.PET Clin. 2018 Oct;13(4):623-634. doi: 10.1016/j.cpet.2018.05.012. Epub 2018 Aug 17. PET Clin. 2018. PMID: 30219192 Free PMC article. Review.
Cited by
-
Positron emission tomography-magnetic resonance imaging applications in pediatric musculoskeletal tumors.Quant Imaging Med Surg. 2024 Nov 1;14(11):7825-7838. doi: 10.21037/qims-24-621. Epub 2024 Oct 24. Quant Imaging Med Surg. 2024. PMID: 39544474 Free PMC article.
References
-
- Hardin AP, Hackell JM, Simon GR, Boudreau ADA, Baker CN, Barden GA, et al. Age limit of pediatrics. Pediatrics. 2017;140:3–5. - PubMed
-
- Schäfer JF, Gatidis S, Schmidt H, Gückel B, Bezrukov I, Pfannenberg CA, et al. Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: Initial results. Radiology. Radiological Society of North America Inc; 2014;273:220–31. - PubMed
-
- Lyons K, Seghers V, Sorensen JIL, Zhang W, Paldino MJ, Krishnamurthy R, et al. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study. AJR Am J Roentgenol. 2015;205:1094–101. - PubMed
-
- Buchbender C, Heusner TA, Lauenstein TC, Bockisch A, Antoch G. Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma. J Nucl Med. 2012;53:1244–52. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
